Abstract

Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call